Paradigm Biocapital Advisors LP - 31 Dec 2024 SCHEDULE 13G/A Report for Olema Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (OLMA)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
Olema Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
OLMA
Shares outstanding
74.4M shares
Disclosed Ownership
7.43M shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:45:39 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 9.99% 7.43M 7.43M 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 9.99% 7.43M 7.43M 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 9.99% 7.43M 7.43M 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 9.1% 6.78M 6.78M 0 /s/ David K. Kim David K. Kim / Authorized Signatory